Skip to main content
. 2010 Nov 9;103(12):1794–1800. doi: 10.1038/sj.bjc.6605960

Table 1. Source, dilution and cut-off values for positivity for different biomarkers.

Marker Antibody (Source) Optimal dilution Positive-control tissue Cut-off values for positivity
ck5/6 D5/16 B4 (Dako UK Ltd, Ely, Cambridgeshire, UK) 1 : 100 Tonsil 10%
ck14 LL002 (Vector Labs, Peterborough, UK) 1 : 100 Skin 10%
ER 1D5 (Dako UK Ltd) 1 : 100 Breast 1%
PGR PGR 636 (Dako UK Ltd) Neat Breast 1%
HER2 DakoA0485 (Dako UK Ltd) 1 : 500 Breast 30% membranous (corresponds to IHC 3+), or if IHC 2+, confirmed by FISH+
p53 DO7 (Dako UK Ltd) 1 : 100 Breast 10% nuclear
EGFR EGFR.113 (Dako UK Ltd) 1 : 50 Skin 10% membranous
Topo2α KI-S1 (Dako UK Ltd) 1 : 100 Tonsil 45% nuclear (high)
KI67 MIB1 (Dako UK Ltd) 1 : 100 Tonsil 10% nuclear (high)

Positive-control tissue is also indicated. Positive HER2 was defined as presence of membrane expression of the protein in >30% of tumour cells (corresponds to IHC 3+) or if underexpressed (2+), confirmed by FISH (fluorescent in situ hybridisation). For p53, Topo2α and Ki67, 100 nuclei were scored for positivity in four random fields ( × 40 magnification) and the total percent-score obtained. Median values of Topo2α were chosen as cut-offs for high or low expression. Other standard cut-offs as per Rakha et al (2006, 2007).